title: Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.
abstract: Krabbe disease is an inherited lysosomal disorder in which galactosylsphingosine (psychosine) accumulates mainly in the central nervous system. To gain insight into the possible mechanism(s) that may be participating in the inhibition of the postnatal somatic growth described in the animal model of this disease (twitcher mouse, twi), we studied their femora. This study reports that twi femora are smaller than of those of wild type (wt), and present with abnormality of marrow cellularity, bone deposition (osteoblastic function), and osteoclastic activity. Furthermore, lipidomic analysis indicates altered sphingolipid homeostasis, but without significant changes in the levels of sphingolipid-derived intermediates of cell death (ceramide) or the levels of the osteoclast-osteoblast coupling factor (sphingosine-1-phosphate). However, there was significant accumulation of psychosine in the femora of adult twi animals as compared to wt, without induction of tumor necrosis factor-alpha or interleukin-6. Analysis of insulin-like growth factor-1 (IGF-1) plasma levels, a liver secreted hormone known to play a role in bone growth, indicated a drastic reduction in twi animals when compared to wt. To identify the cause of the decrease, we examined the IGF-1 mRNA expression and protein levels in the liver. The results indicated a significant reduction of IGF-1 mRNA as well as protein levels in the liver from twi as compared to wt littermates. Our data suggest that a combination of endogenous (psychosine) and endocrine (IGF-1) factors play a role in the inhibition of postnatal bone growth in twi mice; and further suggest that derangements of liver function may be contributing, at least in part, to this alteration.
authors.affiliation: Department of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Miguel Agustin
authors.initials: MA
authors.lastname: Contreras
authors.forename: William Louis
authors.initials: WL
authors.lastname: Ries
authors.forename: Srinivasan
authors.initials: S
authors.lastname: Shanmugarajan
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Arboleda
authors.forename: Inderjit
authors.initials: I
authors.lastname: Singh
authors.forename: Avtar Kaur
authors.initials: AK
authors.lastname: Singh
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001846:Bone Development / Q000502:physiology; D001848:Bone Diseases, Developmental / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D016723:Bone Remodeling / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000378:metabolism; D007965:Leukodystrophy, Globoid Cell / Q000150:complications* / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D008099:Liver / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D011609:Psychosine / Q000378:metabolism; D012307:Risk Factors
chemical_list: D016207:Cytokines; D011609:Psychosine; D007334:Insulin-Like Growth Factor I